Catalent
CTLT
$98.15
Share price
-0.03%
Change (1 day)
-4.43%
Change (1 year)
Categories
Catalent is an American pharmaceutical contract research and development company.
Market capitalization of Catalent (CTLT)
Market cap: $17.58 Billion
As of May 2022 Catalent has a market cap of $17.58 Billion. This makes Catalent the world's 952th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth.
Market cap history of Catalent from 2014 to 2022
| Year | Market cap | Change |
|---|---|---|
| 2022 | $17.99 B | -21.46% |
| 2021 | $22.91 B | 33.71% |
| 2020 | $17.14 B | 107.95% |
| 2019 | $8.24 B | 81.53% |
| 2018 | $4.54 B | -16.81% |
| 2017 | $5.45 B | 62.28% |
| 2016 | $3.36 B | 7.91% |
| 2015 | $3.11 B | -9.71% |
| 2014 | $3.45 B |
End of Day market cap according to different sources
On May 15th, 2022 the market cap of Catalent was reported to be:
$17.59 Billion
$17.99 Billion
$17.59 Billion
$16.80 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Supernus Pharmaceuticals
SUPN | $1.46 B | -91.66% | 🇺🇸 USA |
 Jazz Pharmaceuticals JAZZ | $9.26 B | -47.32% | 🇮🇪 Ireland |
 Intercept Pharmaceuticals
ICPT | $0.55 B | -96.85% | 🇺🇸 USA |